{
  "zip": "T3E 6L1",
  "sector": "Healthcare",
  "fullTimeEmployees": 25,
  "longBusinessSummary": "Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.",
  "city": "Calgary",
  "phone": "403 254 9252",
  "state": "AB",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.resverlogix.com",
  "maxAge": 1,
  "address1": "4820 Richard Road SW",
  "fax": "403 256 8495",
  "industry": "Biotechnology",
  "address2": "Suite 300",
  "previousClose": 0.7102,
  "regularMarketOpen": 0.7068,
  "twoHundredDayAverage": 0.7214388,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.715,
  "navPrice": null,
  "averageDailyVolume10Day": 25562,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.7102,
  "fiftyDayAverage": 0.7290909,
  "trailingAnnualDividendRate": null,
  "open": 0.7068,
  "averageVolume10days": 25562,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.310231,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.6844,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 43.093746,
  "regularMarketVolume": 41829,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 160992720,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 18850,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.6844,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 41829,
  "fiftyTwoWeekHigh": 1.15,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.42,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.715,
  "exchange": "PNK",
  "shortName": "RESVERLOGIX CORP",
  "longName": "Resverlogix Corp.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RVXCF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_3103092",
  "uuid": "25ad5c9b-eff8-3cb5-b9c1-8a66ade2cc8d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -17.349,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 233987008,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.226,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1588204800,
  "heldPercentInstitutions": 0.0001,
  "netIncomeToCommon": 3772000,
  "trailingEps": 0.016,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.50408,
  "nextFiscalYearEnd": 1651276800,
  "mostRecentQuarter": 1604102400,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 140789681,
  "enterpriseValue": 215141952,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.7068,
  "logo_url": "https://logo.clearbit.com/resverlogix.com"
}